Symbiosis Pharmaceutical Services LTD

Our facility was purpose-built to meet increasing market demand for shorter sterile drug product development timelines, while consistently maintaining regulatory compliance.
Today, we reliably support our customers with the aseptic filling and lyophilization of conventional, biologic a...

We offer an efficient clinical labelling and packaging service, which allows us to manage the supply chain logistics of your project and ensure it is delivered to your chosen location. Our goal is to provide a fast and efficient service at all times.

Once your drug product has been m...

As part of our wider service offering, our QPs can release clinical batches under our MHRA IMP license or fully licensed products under a commercial manufacturer/importer’s license. Manufacturing to GMP regulations, we support QP release to clinic, market or direct to you for onward pro...

To assure the quality of your medicinal product and support stability storage testing throughout your drug development programme Symbiosis offers facilities for controlled temperature and humidity storage. Operating to GMP and licensed by the MHRA we adhere to industry guidelines for recording storage temp...

Coordinating in-process and finished product testing with the completion of batch documentation, we can deliver your drug product within just six weeks of the date of manufacture.

Symbiosis Pharmaceutical Services can manage all of your analytical and microbiologial testing requirements by utili...

Symbiosis Pharmaceutical Services Ltd. announced the purchase of new premises in Stirling, Scotland, UK. The new facility and service extension project, supported by a grant from Scottish Enterprise totalling £4.3m ($5.5m), will be implemented over a three-year period as part of a wider £26m ($34.2m) financial commitment by Symbiosis to drive the growth of the company. The growth strategy includes the addition of automated sterile manufacturing production line capabilities to extend the commercial fill/finish services that Symbiosis offers its clients.

Our purpose-built MHRA-licenced manufacturing facility has delivered over 1000 projects for clinical and small-scale commercial products. Our seasoned experts can help guide you through your next manufacturing project. The fundamental aim at Symbiosis is to meet your most demanding timelines by offering access to manufacturing slots within weeks, not months, and ensuring that your critical project is delivered on time, to the highest quality standard.

The CMO's new Chief Operating Officer will continue the company's operational response to COVID-19.

CMO's customer base has grown by more than 25% in 2019 alone, and investment and demand for services is estimated to increase output by another 25-30% in 2020.